GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Achillion Pharmaceuticals, Inc. (ACHN) [hlAlert]

Rating:
Buy ACHN
up 9.95 %

Achillion Pharmaceuticals, Inc. (ACHN) upgraded to Buy with price target $11 by UBS

Posted on: Thursday,  Jun 12, 2014  12:00 AM ET by UBS

UBS rated Buy Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) on 06/12/2014, when the stock price was $6.83. Since
then, Achillion Pharmaceuticals, Inc. has gained 9.96% as of 10/07/2015's recent price of $7.51.
If you would have followed this UBS's recommendation on ACHN, you would have gained 9.95% of your investment in 482 days.

Achillion Pharmaceuticals, Inc. (Achillion) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Within the anti-infective market, it focuses on the development of antivirals for the treatment of chronic hepatitis C and the development of antibacterials for the treatment of resistant bacterial infections. As of December 31, 2008, Achillion focused its efforts on advancing two late-stage preclinical candidates: ACH-1095, an NS4A antagonist for the treatment of chronic hepatitis C, being developed in collaboration with Gilead Sciences, Inc. (Gilead), and ACH-1625, a protease inhibitor also for the treatment of chronic hepatitis C. It has a pipeline of other product candidates, for which it is seeking appropriate collaborative partners. These product candidates include elvucitabine for the treatment of human immunodeficiency virus (HIV) infection and ACH-702 for the treatment of serious bacterial infections.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/12/2014 12:00 AM Buy
None
6.83 11.00
as of 10/17/2014
1 Week up  10.80 %
1 Month down  -8.20 %
3 Months up  64.96 %
1 YTD up  60.61 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/2/2013 11:25 AM Hold
None
6.36 6.50
5/7/2012 12:25 PM Hold
None
5.99 6.00
4/12/2012 11:25 AM Hold
None
9.89 11.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy